• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

勃起功能障碍患者发生心血管疾病的纵向风险——哪些患者更值得关注?

Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?

机构信息

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Unit of Urology, Università Vita-Salute San Raffaele, Milan, Italy.

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

J Sex Med. 2020 Aug;17(8):1489-1494. doi: 10.1016/j.jsxm.2020.03.012. Epub 2020 Apr 24.

DOI:10.1016/j.jsxm.2020.03.012
PMID:32340919
Abstract

BACKGROUND

Erectile dysfunction (ED) is widely considered as an early manifestation of cardiovascular diseases (CVDs), sharing similar risk factors.

AIM

Assess rates and predictors of developing CVD and/or hypertension (HTN) over a long-term follow-up period using user-friendly and clinically reliable tools in men presenting with ED but without CVD/HTN or known vascular risk factors at baseline.

METHODS

Data from 108 patients presenting between 2005 and 2011 with ED were analyzed. All patients were free from CVD and/or HTN (CVD/HTN) at baseline. Patients completed the International Index of Erectile Function (IIEF) at baseline and were followed up every 6 months with clinical assessment or phone interview. Kaplan-Meier analyses estimated the probability of developing CVD/HTN over time. Cox-regression models tested the association between patient baseline characteristics (for example, age, Charlson Comorbidity Index, baseline IIEF-EF, ED severity, alcohol intake, smoking), response to phosphodiesterase type-5 inhibitors (PDE5is), and the risk of developing CVD/HTN.

RESULTS

Of all, 43 (40%) patients showed IIEF-EF scores suggestive of severe ED; 37 (39%) and 59 (61%) were nonresponders and responders to PDE5i, respectively. Median (interquartile range) age was 51 (41, 61) years. Median (interquartile range) follow-up was 95 (86-106) months. Overall, the estimated risk of developing CVD/HTN was 15% (95% confidence interval [CI]: 9-27) at 10-year assessment. Men with baseline severe ED had a higher risk of developing CVD/HTN (34%; 95% CI: 17-59, P = .03) at 10 years than patients with mild to moderate ED (5% [95% CI: 2-14]). At the Cox regression analysis, severe ED (Hazard ratio [HR], 4.62; 95% CI: 1.43, 8.89; P = .01) and baseline IIEF-EF score (HR, 0.92; 95% CI: 0.86, 0.99; P = .02) were associated to the risk of CVD/HTN overtime. Conversely, age and nonresponders to PDE5is (HR, 0.92; 95% CI: 0.32, 2.68; P = .9) were not associated to a risk of CVD/HTN over time.

CLINICAL IMPLICATIONS

The use of an easy and user-friendly tool, as the IIEF-EF domain score, would allow to reliably assess which men with ED at first presentation may deserve a different, more specific and detailed cardiologic investigation to prevent inauspicious CV events.

STRENGTHS & LIMITATIONS: A single-center-based, observational longitudinal study, raising the possibility of selection biases are the main limits.

CONCLUSIONS

Patients with severe ED and lower baseline IIEF-EF but no vascular risk factors at first presentation have more than 30% risk of developing CVD/HTN in 10-year time. Those patients may benefit from medical preventive strategies to lowering the risk of CV events and HTN. Pozzi E, Capogrosso P, Boeri L, et al. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?. J Sex Med 2020;17:1489-1494.

摘要

背景

勃起功能障碍(ED)被广泛认为是心血管疾病(CVDs)的早期表现,具有相似的危险因素。

目的

使用易于使用和临床可靠的工具,评估在基线时没有 CVD/HTN 或已知血管危险因素的情况下出现 ED 的男性在长期随访期间发生 CVD 和/或高血压(HTN)的发生率和预测因素。

方法

分析了 2005 年至 2011 年间出现 ED 的 108 例患者的数据。所有患者在基线时均无 CVD 和/或 HTN(CVD/HTN)。患者在基线时完成了国际勃起功能指数(IIEF),并每 6 个月通过临床评估或电话访谈进行随访。Kaplan-Meier 分析估计了随时间发生 CVD/HTN 的概率。Cox 回归模型测试了患者基线特征(例如年龄、Charlson 合并症指数、基线 IIEF-EF、ED 严重程度、酒精摄入、吸烟)、对磷酸二酯酶 5 抑制剂(PDE5i)的反应与发生 CVD/HTN 的风险之间的关系。

结果

在所有患者中,43 例(40%)患者的 IIEF-EF 评分提示严重 ED;37 例(39%)和 59 例(61%)分别是非反应者和 PDE5i 反应者。中位(四分位距)年龄为 51(41,61)岁。中位(四分位距)随访时间为 95(86,106)个月。总体而言,在 10 年评估时,估计发生 CVD/HTN 的风险为 15%(95%置信区间[CI]:9-27)。基线时患有严重 ED 的男性发生 CVD/HTN 的风险(34%;95%CI:17-59,P=0.03)高于轻度至中度 ED 的患者(5%;95%CI:2-14)。在 Cox 回归分析中,严重 ED(危险比[HR],4.62;95%CI:1.43,8.89;P=0.01)和基线 IIEF-EF 评分(HR,0.92;95%CI:0.86,0.99;P=0.02)与 CVD/HTN 的风险随时间增加相关。相反,年龄和 PDE5i 无反应者(HR,0.92;95%CI:0.32,2.68;P=0.9)与 CVD/HTN 的风险随时间增加无关。

临床意义

使用易于使用和用户友好的工具,如 IIEF-EF 域评分,可以可靠地评估首次出现 ED 的男性中哪些人可能需要进行不同的、更具体和详细的心脏检查,以预防不利的心血管事件。

优势与局限性

这是一项单中心、观察性纵向研究,存在选择偏倚的可能性,这是主要的局限性。

结论

首次就诊时患有严重 ED 和较低基线 IIEF-EF 但无血管危险因素的患者,在 10 年内发生 CVD/HTN 的风险超过 30%。这些患者可能受益于降低心血管事件和 HTN 风险的医疗预防策略。

相似文献

1
Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?勃起功能障碍患者发生心血管疾病的纵向风险——哪些患者更值得关注?
J Sex Med. 2020 Aug;17(8):1489-1494. doi: 10.1016/j.jsxm.2020.03.012. Epub 2020 Apr 24.
2
Spontaneous erectile function recovery among young men with erectile dysfunction taking tadalafil 5 mg once a day.每日服用他达拉非 5 毫克的勃起功能障碍年轻男性自发勃起功能恢复。
J Sex Med. 2024 Aug 1;21(8):671-675. doi: 10.1093/jsxmed/qdae064.
3
Should We Tailor the Clinical Management of Erectile Dysfunction According to Different Ages?是否应根据不同年龄制定勃起功能障碍的临床管理策略?
J Sex Med. 2019 Jul;16(7):999-1004. doi: 10.1016/j.jsxm.2019.03.405. Epub 2019 Apr 30.
4
Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain.勃起功能障碍是否能可靠地反映男性整体健康状况?国际勃起功能指数-勃起功能域的案例。
J Sex Med. 2012 Oct;9(10):2708-15. doi: 10.1111/j.1743-6109.2012.02869.x. Epub 2012 Aug 15.
5
Change in Frequency and Predictors of Erectile Dysfunction With Changes in the International Index of Erectile Function-Erectile Function Domain Score in Patients With ST-Elevation Myocardial Infarction: A Prospective, Longitudinal Study.ST 段抬高型心肌梗死患者国际勃起功能指数-勃起功能域评分变化与勃起功能障碍频率变化及预测因素:一项前瞻性纵向研究。
J Sex Med. 2020 Jun;17(6):1101-1108. doi: 10.1016/j.jsxm.2020.03.002. Epub 2020 Mar 25.
6
Unrecognized Prediabetes Is Highly Prevalent in Men With Erectile Dysfunction-Results From a Cross-Sectional Study.未被识别的糖尿病前期在勃起功能障碍男性中高度普遍-一项横断面研究的结果。
J Sex Med. 2018 Aug;15(8):1117-1124. doi: 10.1016/j.jsxm.2018.06.009.
7
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.他达拉非每日一次治疗男性勃起功能障碍:六项随机、双盲、安慰剂对照临床试验 1913 例患者数据的综合分析。
Eur Urol. 2014 Feb;65(2):455-64. doi: 10.1016/j.eururo.2013.09.037. Epub 2013 Oct 2.
8
Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.治疗勃起功能障碍的安慰剂对男性勃起功能正常化的预测因素。
J Sex Med. 2018 Jun;15(6):866-872. doi: 10.1016/j.jsxm.2018.03.089. Epub 2018 May 9.
9
Comparison of international index of erectile function with nocturnal penile tumescence and rigidity testing in evaluation of erectile dysfunction.国际勃起功能指数与夜间阴茎胀大及硬度测试在勃起功能障碍评估中的比较
Int J Impot Res. 2006 Mar-Apr;18(2):186-9. doi: 10.1038/sj.ijir.3901390.
10
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study.年轻勃起功能障碍患者的临床特征:一项真实世界横断面研究的初步发现。
Eur Urol Focus. 2020 Jan 15;6(1):184-189. doi: 10.1016/j.euf.2018.10.003. Epub 2018 Oct 11.

引用本文的文献

1
Comment on: Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data.评论:与胰高血糖素样肽-1受体激动剂相关的男性性功能障碍:FAERS数据的横断面分析
Int J Impot Res. 2025 Jul 18. doi: 10.1038/s41443-025-01126-2.
2
Advances in stem cell therapy for erectile dysfunction: preclinical evidence and emerging therapeutic approaches.用于勃起功能障碍的干细胞疗法进展:临床前证据及新兴治疗方法
Front Med (Lausanne). 2025 Apr 2;12:1519095. doi: 10.3389/fmed.2025.1519095. eCollection 2025.
3
A Narrative Review of Independent Treatment Methods for ED: Assessment of the Effectiveness of Diet, Supplements, Pharmacotherapy, and Physiotherapy.
勃起功能障碍独立治疗方法的叙述性综述:饮食、补充剂、药物治疗和物理治疗的有效性评估
J Clin Med. 2025 Mar 31;14(7):2386. doi: 10.3390/jcm14072386.
4
Bedtime sildenafil oral suspension improves sexual spontaneity and time-concerns compared to on-demand treatment in men with erectile dysfunction: results from a real-life, cross-sectional study.与按需治疗相比,睡前服用西地那非口服混悬液可改善勃起功能障碍男性的性自发性和时间顾虑:一项真实生活横断面研究的结果
Int J Impot Res. 2025 Feb 24. doi: 10.1038/s41443-025-01035-4.
5
Effectiveness and patient satisfaction with the new sildenafil oral suspension formulation compared to sildenafil oro-dispersible film: a real-life study.与西地那非口腔崩解膜相比,新型西地那非口服混悬液制剂的有效性及患者满意度:一项真实世界研究。
Int J Impot Res. 2025 Jan 29. doi: 10.1038/s41443-025-01019-4.
6
Sildenafil oral suspension formulation for erectile dysfunction: is it love at first sight?用于治疗勃起功能障碍的西地那非口服混悬液制剂:这是一见钟情吗?
Int J Impot Res. 2025 Jan 24. doi: 10.1038/s41443-025-01016-7.
7
Use of phosphodiesterase 5 inhibitors is not associated with ocular adverse events.使用磷酸二酯酶 5 抑制剂与眼部不良事件无关。
J Sex Med. 2023 Nov 30;20(12):1399-1406. doi: 10.1093/jsxmed/qdad137.
8
The retinal neurovascular coupling is impaired in men with vasculogenic erectile dysfunction.视网膜神经血管耦合在血管性勃起功能障碍的男性中受损。
Sci Rep. 2023 May 22;13(1):8237. doi: 10.1038/s41598-023-35339-6.
9
Vascular endothelium is the basic way for stem cells to treat erectile dysfunction: a bibliometric study.血管内皮是干细胞治疗勃起功能障碍的基本途径:一项文献计量学研究。
Cell Death Discov. 2023 May 1;9(1):143. doi: 10.1038/s41420-023-01443-9.
10
Analysis of the relationship between sexual satisfaction, erectile dysfunction, and penile vascular parameters in a cohort of patients.一组患者中性满意度、勃起功能障碍与阴茎血管参数之间关系的分析。
Transl Androl Urol. 2021 Dec;10(12):4313-4319. doi: 10.21037/tau-21-792.